ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
72 announcements
UGRO Capital Limited confirmed the issuance and full utilization of ₹270 Crore in Commercial Paper proceeds for the quarter ended March 31, 2026. The company certified adherence to listing conditions across seven different ISINs. Most instruments are unlisted, with one listed on the BSE.
UGRO Capital Limited has submitted its Asset/Liability Management statement for the quarter ended March 31, 2026. The disclosure, filed under SEBI and RBI requirements, details the company's structural liquidity and interest rate sensitivity. This routine regulatory filing provides transparency into the firm's liquidity position and risk management framework for investors.
UGRO Capital Limited confirmed timely interest payments totalling ₹2.01 Crore for three series of Non-Convertible Debentures (ISINs: INE583D07463, INE583D08099, and INE583D07620). The payments were made between April 24-27, 2026, complying with SEBI Listing Obligations and Disclosure Requirements.
UGRO Capital reports Q4'FY26 PAT of ₹51.1 Cr (YoY +26%) with AUM at ₹15,334 Cr. The company is executing a strategic realignment toward high-yield Emerging Market LAP and Embedded Merchant Finance verticals.
UGRO Capital reported a full-year FY26 PAT of ₹174.8 Crore (+21% YoY) and Q4'FY26 PAT of ₹51.1 Crore. Total AUM reached ₹15,334 Crore, driven by growth in high-yield focus verticals. The company confirmed that all strategic realignment objectives are on track, with no further equity raises planned through FY29.
Ugro Capital Limited's board approved the re-appointment of Mr. Shachindra Nath as Executive Director and MD for a five-year term effective June 2026. Additionally, M/s G P Kapadia & Co was appointed as Statutory Auditor for 36 months, succeeding M/s Sharp & Tannan upon their tenure completion.
UGRO Capital Limited submitted its Security Cover Certificate for the quarter and financial year ended March 31, 2026. Certified by M/s Sharp & Tannan Associates, the report confirms the company maintains adequate asset cover for its secured listed debt securities in compliance with SEBI regulations.
UGRO Capital's board approved audited FY26 financial results and a ₹3,000 Crore NCD issuance. The board also recommended the re-appointment of Mr. Shachindra Nath as MD for five years and the appointment of M/s G.P. Kapadia & Co. as new statutory auditors.
UGRO Capital's board approved audited FY26 financial results and a ₹3,000 Crore NCD issuance. The board also recommended the re-appointment of Mr. Shachindra Nath as MD for five years and the appointment of M/s G.P. Kapadia & Co. as new statutory auditors.
UGRO Capital Limited has scheduled a Board Meeting on April 20, 2026, to approve annual audited financial results for FY26. The board will also consider fund-raising proposals through the issuance of debt securities and equity shares via QIP, alongside convening the company's 33rd Annual General Meeting.
UGRO Capital Limited has scheduled a Board Meeting on April 20, 2026, to consider audited yearly financial results and multiple fund-raising options. Potential capital raises include a QIP, preferential issue, and debt issuance. The company's trading window is closed from March 27 until April 22, 2026.
Ugro Capital Limited has successfully allotted Commercial Papers through a private placement on April 9, 2026. This debt issuance follows board approval on the same day. The transaction reflects the company's ongoing efforts to diversify its short-term funding sources and manage liquidity.